Clinical Trial Update: Immunotherapy in Patients With Early dMMR Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating immunotherapy for patients with early dMMR rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Odense University Hospital | Conditions: Cancer of Rectum | Phase 2 | Status: RECRUITING